aceOptimizing Portal Venous Phase Acquisition Quality of Contrast-Enhanced CT in Oncology
Background: Portal venous phase (PVP) contrast-enhanced CT is a cornerstone for response assessment in early-phase oncology trials, yet contrast-enhancement phase timing remains insufficiently monitored across sites. We assessed PVP timing using a validated artificial intelligence (AI) quality control tool (CECT-QC). Methods: In this retrospective multicenter study, 402 CT examinations from 402 patients enrolled in phase I oncology trials across three European institutions were analyzed using CECT-QC, which quan…
An AI quality-control tool classified only 53.1% of standard CT examinations in phase I oncology trials as optimal portal venous phase, with significant variation across institutions and scanner types.
The study was retrospective, and the classification tool needs adaptation to emerging CT platforms such as photon-counting CT, limiting how far the findings generalize.
Evidence
- Peer-reviewedDiagnostics2026-10-16
How should this claim be treated?
Truvace Impact Record TRV-2026-1699, v1: “Optimizing Portal Venous Phase Acquisition Quality of Contrast-Enhanced CT in Oncology.” Truvace, 2026-10-17. /record/TRV-2026-1699 (accessed at citation time). sha256 2bad39e92dded9c4…
Calibration history
Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.
Certified into the record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-1699 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.